Maddox Pharma Swiss Revenue and Competitors

Zug, CHE

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Maddox Pharma Swiss's estimated annual revenue is currently $25.1M per year.(i)
  • Maddox Pharma Swiss's estimated revenue per employee is $201,000

Employee Data

  • Maddox Pharma Swiss has 125 Employees.(i)
  • Maddox Pharma Swiss grew their employee count by 18% last year.

Maddox Pharma Swiss's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$16.3M8125%N/AN/A
#2
$17.5M8726%N/AN/A
#3
$170.6M849-9%N/AN/A
#4
$9.4M47-10%N/AN/A
#5
$20.1M10027%N/AN/A
#6
$8.8M4447%N/AN/A
#7
$10.3M5146%N/AN/A
#8
$182.5M90817%N/AN/A
#9
$48.4M24119%N/AN/A
#10
$11.3M5640%N/AN/A
Add Company

What Is Maddox Pharma Swiss?

Maddox Pharma Swiss is a European Pharmaceutical Company, was established in 2015, specialized in both Pharmaceuticals and Food supplements. Maddox Pharma Swiss supplies high-quality products across the global markets. Our mission is to enhance people's health and quality of life by providing a rich product portfolio and services that match their needs. In Maddox Pharma Swiss, we are continuously consolidating our position as a leading supplier of generic pharmaceuticals as well as food supplements worldwide. We aim to achieve this by strengthening the long-term relationship with all the stakeholders in terms of development, product supply, and marketing of value-added products and services. Our Values • Act with honesty as we believe in our responsibility towards our customers. • Value our customers and their needs. • Committed to improve efficiency with the highest standards of performance to achieve our goals. • Operate clearly and openly, to ease others to observe our performance.

keywords:N/A

N/A

Total Funding

125

Number of Employees

$25.1M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.1M12518%N/A
#2
$16.5M127-23%$108M
#3
$25.6M13575%N/A
#4
$20M13828%N/A
#5
$20.2M13917%N/A